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Abstract T7 RNA polymerase is shown to recognize the SP6 
promoter including 17 base pairs before the transcription start 
site and produce the 5'-end TBEV RNA. The yield of TBEV 
RNA synthesized by heterologous T7 RNA polymerase from 
cDNA construction with SP6 promoter is higher than the RNA 
production by homologous SP6 RNA polymerase. The addition 
of 1 pmol template DNA with SP6 17 bp promoter in 
transcription mixture for SP6 or T7 RNA polymerases resulted 
in 1-5 × 10 -2 pmol RNA production. 
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1. Introduction 
The bacteriophage T7 grows on Escherichia coli cells. Bac- 
teriophage T7 RNA polymerase (EC 2.7.7.6) is produced early 
in T7 infection [1]. A single-chain enzyme with a molecular 
weight close to 100000, T7 RNA polymerase has a stringent 
specificity for its own promoters and selectively transcribes 
DNA that has been linked to such promoters [2]. Seventeen 
such promoters are found in T7 DNA. Nucleotide sequence 
analysis revealed that 5 strong late promoters (class III) con- 
sist of 23 bp including the start site for the RNA (from - 17 to 
+6) [3], whereas 10 weak promoters of class II contain 2-7 
modified nucleotides that differ from the class III promoter 
sequence and do not include the transcription start [4]. Two 
other promoters are near the 5' and 3' ends of T7 DNA [5]. 
The bacteriophage SP6 grows only on recipient Salmonella 
typhimurium strains and not on donor strains [6]. Bacterio- 
phage SP6 encode a single subunit RNA polymerase (EC 
2.7.7.6) that is very similar to the T7 RNA polymerase [7]. 
Comparison of the SP6 consensus sequences with the struc- 
tures of promoters recognized by T7 and T3 RNA polymerase 
revealed a common core sequence (5'- CACTA-3') extending 
from -7  to -3  [7]. 
Recombinant DNA technology makes it possible to pro- 
duce cDNA clones corresponding to the genomes of RNA 
viruses and infectious RNA by transcription i vitro [8-11]. 
However, the presence of nonviral nucleotides at the 5' end of 
viral transcripts strongly reduces infectivity [8], so the using of 
commercially available in vitro transcription vectors with 
strong SP6 or T7 promoters leads to uninfectious RNA tran- 
scripts with additional vector-derived sequences at the 5' end. 
To study TBEV infection we have constructed full-length 
cDNA as described previously [12]. In order to obtain recov- 
ered virus we had to introduce weak SP6 promoter by means 
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of synthetic oligodeoxyribonucleotides upstream of the 5' end 
of the full-length TBEV cDNA. The transcription of 5' end 
TBEV cDNA in vitro by homologous SP6 or heterologous T7 
DNA-dependent RNA-polymerases resulted in the production 
of radioactive infectious RNA without additional nucleotides 
at the 5' end. 
2. Materials and methods 
2.1. Construction of full-length TBEV cDNA with SP6 promoter 
The pBR322TBEVS* plasmid has been described previously [12]. 
The NotI-Sphl fragment of pBR322TBEVS* was replaced on the 
double-stranded oligodeoxyribonucleotide, containing SP6 promoter, 
the additional transcription-initiating G residue and the first nucleo- 
tides of TBEV cDNA (Fig. 1B). The introduction of the SP6 promo- 
ter upstream of the 5' end of pBR322TBEVS* resulted in pS-TBEVS* 
plasmid construction (Fig. IA). 
2.2. [T-32p]ATP and [a-32P]GTP synthesis 
[T-32p]ATP and [o~-32p]GTP were synthesized from [32P]orto-phos- 
phoric acid (Obninsk Physik-energetic Institute, Russia) as described 
in [13]. 
2.3. Determination fnucleotide sequence using Taq DNA polymerase 
Nucleotide sequence of promoter region and 5' end TBEV cDNA 
of pS-TBEVS* plasmid has been determined by the method of Murray 
[14] using Taq DNA polymerase (Promix, Russia) and dideoxy-NTP 
(Boehringer Mannheim, Germany). 
2.4. In vitro RNA transcription 
The pS-TBEVS* plasmid was linearized by cleavage with Xhol re- 
striction endonuclease. 32p-Labeled RNA was synthesized bySP6 or 
T7 DNA-dependent RNA polymerases (Promix, Russia) and 50 ktM 
[a-3Zp]GTP (10 cpm/ml) for 3 h at 37°C as described in [15]. The 
labeled RNA production was estimated by incorporation of [ct- 
32p]GTP into TCA-insoluble product. The samples of reaction mix- 
ture placed on GF/C filters (Whatman, UK) were washed 4 times for 
15 rain each by cold 5% CCI3COOH with 1 mM Na4P207 on ice and 
(~erenkov counted on a 1211 MiniBeta (LKB, Sweden). The RNA 
products were analyzed by the denaturating 5% PAAG-7 M urea 
gel electrophoresis in 1 × TBE buffer with subsequent autoradiogra- 
phy. 
3. R~d~ 
Since the additional nonviral nucleotides at the 5' end of 
viral RNA transcripts strongly decrease the infectivity of re- 
covered viruses [8] we had to introduce the weak 17 bp SP6 
promoter upstream of the 5' end of pBR322TBEVS* as fol- 
lowing (Fig. 1A). The NotI-SphI fragment of pBR322TBEVS* 
was replaced by double-stranded oligonucleotide, which con- 
tained the SP6 promoter, the additional transcription-initiat- 
ing G residue and fragment of the 5' end of TBEV cDNA and 
was flanked by stick-ends for NotI and SphI (Fig. 1B). Nu- 
cleotide sequences of promoter and the following 5' end of 
pS-TBEVS* were determined by dideoxynucleotides according 
to [14]. 
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Fig. 1. A: Scheme of pS-TBEVS* plasmid construction. 
pBR322TBEVS* plasmid was hydrolysed by the restriction endonu- 
cleases NotI and SphI. The double-stranded oligodeoxyribonucleo- 
tide containing promoter for DNA-dependent RNA polymerase of 
bacteriophage SP6 was ligated with prepared plasmid, It resulted in 
plasmid pS-TBEVS* construction with SP6 promoter upstream of 
the full-length eDNA of TBEV. B: Structure of the double-stranded 
oligodeoxyribonucleotide us d for pS-TBEVS* plasmid construction. 
The pS-TBEVS* plasmid was linearized by XhoI restriction 
endonuclease. The unique XhoI site is nearly 5700 bp from the 
5' end of TBEV eDNA (Fig. 1A). The TBEV RNA was 
synthesized in vitro in standard condition [15]. The ethidium 
bromide (1 lig/ml) stainning of 1% agarose gel with 0.1% SDS 
or 5% PAAG-7 M urea did not allow the detection of RNA 
transcripts (data not shown). However, RNA synthesis in the 
presence of [et-a2p]GTP [13] with subsequent denaturating 
electrophoresis in 5% PAAG-7 M urea and autoradiography 
resulted in transcription detection (Fig. 2). Therefore the 
RNA synthesis level is extremely low. 
The incorporation of [a-a2p]GTP into TCA-insoluble pro- 
duct revealed 0.7% incorporation only. The comparison of 
kinetic curves (Fig. 3) showed the higher effectivity of RNA 
synthesis from the same template DNA with short SP6 pro- 
moter by T7 RNA polymerase than with SP6 RNA polymer- 
ase. Taking into account he [et-32p]GTP specific radioactivity, 
the percentage of substrate incorporation into RNA product 
and the length of RNA, 5700 nucleotides, one can estimate 
the effectivity of RNA synthesis from heterologous promoter 
as 20-100× 10 -2 pmol RNA from 1 pmol DNA. Therefore 
the TBEV 5' end RNA yield appeared to be the same in 
transcription reaction with SP6 and T7 RNA polymerases. 
4. Discuss ion 
Because SP6 and T7 RNA polymerase are similar and their 
promoters have a consensus extending from -7  to -3 ,  it is 
reasonable to expect cross-reactions in heterologous combina- 
tions between enzyme and template. However, the T7 RNA 
polymerase has a stringent specificity for its own promoter as 
shown previously by transcription reaction in vitro with sub- 
sequent 1% agarose gel electrophoresis and ethidium bromide 
staining of nascent RNA [2]. Only few if any promoters for 
T7 RNA polymerase are found in any DNA unrelated to T7. 
This great specificity of T7 RNA polymerase for its own pro- 
moter is extremely important for bacteriophage T7 infection 
and useful to biochemists. Nevertheless, SP6 and T7 bacter- 
iophages multiply on different hosts Salmonella typhimurium 
and Escheriehia coli, respectively. Therefore they could never 
interact with one another in vivo. The similarity of SP6 and 
T7 RNA polymerases and their promoters might be the result 
of convergent evolution. The consensus equence 5'-CACTA- 
3' of SP6 and T7 promoters contains only 5 nucleotides so it 
might be a very weak promoter only. Indeed, the effectivity of 
transcription of the same DNA with SP6 promoter of 17 bp 
long by homologous SP6 and heterologous T7 RNA poly- 
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Fig. 2. Autoradiogram of RNA products after in vitro transcription 
of the pS-TBEVS* plasmid. Lane 1 shows the product of RNA 
transcription by SP6 DNA-dependent RNA polymerase, lane 2 that 
of T7 DNA-dependent RNA polymerase. 'Start' means the begin- 
ning of the PAAG. 
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Fig. 3. Kinetic of in vitro RNA transcription determined by incor- 
poration of ct-32P-labeled GTP into acid-insoluble product. O indi- 
cates RNA synthesis with SP6 RNA polymerase, zx indicates RNA 
synthesis with T7 RNA polymerase. 
merases is similar. Concequently, class II promoter of bacter- 
iophage SP6 might possibly bind with both SP6 and T7 DNA-  
dependent RNA polymerases. 
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